Science Impact 2025 – tomorrow's solutions start today?

Spend a day with great science, innovation and networking opportunities at this meeting place for academia, the institute sector, the public sector, start-ups and industry.? The conference is a part of Oslo Innovation Week 2025. Topics: antimicrobial resistance, cancer, neuroscience, materials science, social innovation, and women's health. 

Illustration title conference and logos

At this conference we focus on initiatives in academia and industry and the need for collaboration as well as framework conditions needed to put research to use for the benefit of patients and society.

Sign up!

Programme

08:00–08:30 Registration and breakfast

Place: Area outside Forum auditorium

08:30–10:00 Impact Breakfast: Antimicrobial resistance – a global challenge with urgent need for new solutions

Place: Area outside Forum auditorium

Hilde NebbKristian TonbyTone T?njumGeir KlinkenbergP?l RongvedKristin L?sethElizaveta VereshchaginaJukka Corander

  • Welcome to Science Impact 2025
    Hilde Nebb, Professor, innovation director, UiO Growth House
  • Global and national perspectives – what has been, what is and what will be?
    Kristian Tonby, MD, PhD, associate professor, Institute of Clinical Medicine, UiO and Oslo OUS
  • New therapy against drug-resistant tuberculosis
    Tone T?njum, Professor, Institute of Clinical Medicine, UiO and OUS
  • What does it take to develop a new antibiotic? – from bioprospecting to AI-supported identification
    Geir Klinkenberg, research manager, SINTEF
  • Inventing and developing novel resistance breakers
    P?l Rongved, CSO, AdjuTec Pharma AS and professor emeritus, Department of Pharmacy, UiO
  • Development of new antibiotics from the perspectives of a large pharmaceutical company
    Kristin L?seth, medical director Norway, AstraZeneca
  • Developing diagnostic device to detect drug resistant bacteria
    Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF
  • Precision-guided missiles to target harmful bacteria
    Jukka Corander, Institute of Basic Medical Sciences, UiO

10:00–10:30 Networking

10:30–12:00 Parallel sessions

Cancer treatment – Oslo a world-leading hub for radiopharmacy

Place: Forum auditorium

Mona Elisabeth Rootwelt-RevheimSunniva Siem?ystein SougJenny Karlsson

  • Theranostics – targeted radionuclide therapy 
    Mona Elisabeth Rootwelt-Revheim, MD, PhD, professor II, head of The Intervention Centre, UiO and OUS
  • Building competence and infrastructure on radionuclides 
    Sunniva Siem, professor Department of Physics UiO, and centre director, the Norwegian Nuclear Research Centre
  • Transforming cancer through direct alpha therapy
    ?ystein Soug, CEO, Oncoinvent
  • Challenging cancer indications met with challenging technology
    Speaker TBA, ARTBIO

  • Development of radionuclides from the perspectives of a large pharmaceutical company
    Jenny Karlsson, senior director targeted radiopharmaceuticals, Bayer

Materials science advancing medical research and development

Place: Toppsenteret

Joel GloverMichal MielnikSteven Ray WilsonFr?ydis Sved SkottvollFlorian DapsanceElizaveta Vereshchagina

  • New technology for precision human tissue and modeling of neurodegenerative diseases
    Joel Glover, professor, Institute of Basic Medical Sciences, UiO and Michal Mielnik, research manager, SINTEF
  • PharmaChip: Robust, automated, and sustainable chemical analysis of organoids and organ-on-chip systems
    Steven Ray Wilson, professor, Department of Chemistry, UiO and Fr?ydis Sved Skottvoll, PhD, research scientist, SINTEF 
  • Towards more flexible, biocompatible and less invasive brain implants
    Florian Dapsance, PhD candidate, Department of Physics, UiO
  • BreathSense – transforming COPD patient care with ground-breaking hand-held breath diagnostics sensor technology 
    Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF

Speakers from companies to come.

12:00–13:00 Networking and lunch

Place: Area outside Forum auditorium and Toppsenteret

13:00–14:30 Parallel sessions

Neuroscience – better diagnosis and treatment of Alzheimer's, Parkinson's and multiple sclerosis

Place: Forum auditorium

Kristian Selb?kMagnar Bj?r?sGro NygaardSusanne FabrePer Wessel NoreJ?rn Thomas Waagb?

  • Global and national perspectives on a growing challenge – what has been, what is and what will be?
    Geir Selb?k, MD, PhD, professor II, Institute of Clinical Medicine, UiO, and research director, The Norwegian National Centre for Ageing and Health
  • Modeling brain disease using organoids, 
    Magnar Bj?r?s, PhD, researcher, Institute of Clinical Medicine, UiO and OUS and professor, NTNU
  • Therapeutic trials and vaccine studies in multiple sclerosis (MS)
    Gro Owren Nygaard, MD, PhD, researcher, Institute of Clinical Medicine, UiO and OUS
  • Research and development in the field of neurodegenerative disorders in a large pharmaceutical company
    Susanne Fabre, PhD, senior director translational biomarkers and bioanalysis, BioArctic
  • Personalized neuro diagnostics with AI
    Per Wessel Nore, CEO, baba
  • Deep brain stimulation therapy for Parkinson's
    J?rn Thomas Waagb?, therapy specialist, Medtronic
  • Next generation biomarkers for neurodegenerative diseases
    Speaker TBA, Pre Diagnostics

Social innovation

Place: Toppsenteret

Markus BuggeTaran ThuneMagnus Gulbrandsen

14:30–15:00 Networking

Place: Area outside Forum auditorium and Toppsenteret

15:00–16:30 Impact Afternoon: Women's health research and development

Place: Forum auditorium

Anne EskildHanne Haslene-HoxPeter FedorcsakEsmaeil DorrajiVilde Teigene M?l?y

  • Imaging pregnancies with new AI-technologies
    Anne Eskild, MD, PhD, professor II, Institute of Clinical Medicine, UiO and Akershus University Hospital (Ahus) 
  • Developing new methods to diagnose and treat endometriosis
    Hanne Haslene-Hox, PhD, senior research scientist, SINTEF
  • Bed-side test to determine fertile days and improve IVF outcome
    Peter Fedorcsak, MD, PhD, professor II, Institute of Clinical Medicine, UiO and OUS
  • New therapy against breast cancer
    Esmaeil Dorraji, PhD, CSO and founder, Immunoquest Therapeutics AS
  • Gender differences in stroke
    Vilde Teigene M?l?y, PhD candidate, UiO, OUS and The Norwegian Air Ambulance Foundation 
  • R&D on women's health in a large pharmaceutical company
    Speaker TBA, Bayer

16:30–17:00 Networking with refreshments

Place: Area outside Forum auditorium

Organisers

Main organiser: UiO Growth House

Internal partners at the University of Oslo (UiO): Faculty of Medicine, Faculty of Mathematics and Natural Sciences, Centre for Global Sustainability, Department of Informatics, Centre for Materials Science and Nanotechnology and SPARK Social Innovation

External partners: Inven2, SINTEF, The Life Science Cluster, Nansen Neuroscience Network, Oslo Cancer Cluster, LMI, Oslo University Hospital (OUS), Oslo Science City and Oslo Science Park

Questions?

Please contact the UiO Growth House, Norunn K. Torheim, Head of communications and public and external relations, at norunnt@uio.no

See the programme and pictures from Science Impact 2024 and Science Impact 2023.

Published Nov. 21, 2024 11:12 AM - Last modified June 25, 2025 1:03 PM